Cost-Effectiveness Evaluation of Bariatric Surgery for Morbidly Obese with Diabetes Patients in Thailand

<table class="table-group" id="tab8"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td class="align_left">Parameters</td><td class="align_center">Value</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left">Incremental cost (BSG vs. non-BSG)</td><td class="align_center">76,117.83</td></tr><tr><td class="align_left">Incremental life-year gain (LYG)</td><td class="align_center">3.30</td></tr><tr><td class="align_left">Discounted ICER</td><td class="align_center">23,049.92</td></tr><tr><td class="align_left">Incremental cost (BSG vs. non-BSG)</td><td class="align_center">76,117.83</td></tr><tr><td class="align_left">Incremental discounted QALY</td><td class="align_center">2.83</td></tr><tr><td class="align_left">Discounted ICUR</td><td class="align_center">26,907.76</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td><div>BSG: bariatric surgery group; ICER: incremental cost-effectiveness ratio; QALY: quality-adjusted life-year; ICUR: incremental cost utility ratio.<br/></div></td></tr></table>

<div>Incremental cost-effectiveness and incremental cost utility ratio.</div>

Journal of Obesity

tab8

Table 8

Table 8: Cost-Effectiveness Evaluation of Bariatric Surgery for Morbidly Obese with Diabetes Patients in Thailand 